Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Declining Predictive Performance of the MELD: Cause for Concern or Reflection of Changes in Clinical Practice?

Mahmud N, Goldberg DS.

Am J Transplant. 2019 Sep 25. doi: 10.1111/ajt.15606. [Epub ahead of print]

PMID:
31553133
2.

Temporal Changes and Regional Variation in Acceptance of HCV-viremic Livers.

Mazur RD, Goldberg DS.

Liver Transpl. 2019 Sep 20. doi: 10.1002/lt.25644. [Epub ahead of print]

PMID:
31539195
3.

National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys.

Potluri VS, Goldberg DS, Mohan S, Bloom RD, Sawinski D, Abt PL, Blumberg EA, Parikh CR, Sharpe J, Reddy KR, Molnar MZ, Sise M, Reese PP.

J Am Soc Nephrol. 2019 Oct;30(10):1939-1951. doi: 10.1681/ASN.2019050462. Epub 2019 Sep 12.

PMID:
31515244
4.

Caught in the Web - U.S. Immigration and Compound Disadvantage.

Berger ZD, Goldberg DS.

N Engl J Med. 2019 Sep 12;381(11):993-995. doi: 10.1056/NEJMp1902966. No abstract available.

PMID:
31509671
5.

Trends in deceased donor liver enzymes prior to transplant: The impact on graft selection and outcomes.

Kaltenbach MG, Harhay MO, Abt PL, Goldberg DS.

Am J Transplant. 2019 Aug 17. doi: 10.1111/ajt.15573. [Epub ahead of print]

PMID:
31420967
6.

Seroprevalence of H. pylori Infection in a National Cohort of Veterans With Non-Cardia Gastric Adenocarcinoma.

Kumar S, Metz DC, Kaplan DE, Goldberg DS.

Clin Gastroenterol Hepatol. 2019 Jul 20. pii: S1542-3565(19)30770-0. doi: 10.1016/j.cgh.2019.07.026. [Epub ahead of print]

PMID:
31336199
7.

Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma.

Kanneganti M, Mahmud N, Kaplan DE, Taddei TH, Goldberg DS.

Transplantation. 2019 Jun 24. doi: 10.1097/TP.0000000000002816. [Epub ahead of print]

PMID:
31283688
8.

Use of public health service increased risk kidneys in pediatric renal transplant recipients.

Meyers MR, Shults J, Laskin B, Porrett P, Levine M, Abt P, Amaral S, Goldberg DS.

Pediatr Transplant. 2019 Aug;23(5):e13405. doi: 10.1111/petr.13405. Epub 2019 Jul 4.

PMID:
31271263
9.

The use of induction therapy in liver transplantation is highly variable and is associated with post-transplant outcomes.

Bittermann T, Hubbard RA, Lewis JD, Goldberg DS.

Am J Transplant. 2019 Jun 27. doi: 10.1111/ajt.15513. [Epub ahead of print]

PMID:
31243887
10.

Reply to Letters to the Editor: Diverging Definitions and Dividing Lines in Acute-on-Chronic Liver Failure.

Mahmud N, Kaplan DE, Taddei TH, Goldberg DS.

Hepatology. 2019 Jun 27. doi: 10.1002/hep.30835. [Epub ahead of print]

PMID:
31243784
11.

Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality.

Mahmud N, John B, Taddei TH, Goldberg DS.

Clin Transplant. 2019 Jul;33(7):e13634. doi: 10.1111/ctr.13634. Epub 2019 Jun 25.

PMID:
31177570
12.

In-Hospital mortality varies by procedure type among cirrhosis surgery admissions.

Mahmud N, Fricker Z, Serper M, Kaplan DE, Rothstein KD, Goldberg DS.

Liver Int. 2019 Aug;39(8):1394-1399. doi: 10.1111/liv.14156. Epub 2019 Jun 17.

PMID:
31141306
13.

First report the findings: genuine balance when reporting CTE.

Casper ST, Golden J, Oreskes N, Largent M, Goldberg DS, Gillett G, Philpott-Jones S, Moreira T, Virdi J, Meyers T, Morrison D, Rodriguez JE, Gabriel JM, Steere-Williams J, Ross R, Smith JM, Ballenger JF, Bil G, Kawaguchi Y, Dyck E, Callard F, Ortega F, Kleinman S, Brown M.

Lancet Neurol. 2019 Jun;18(6):522-523. doi: 10.1016/S1474-4422(19)30158-9. No abstract available. Erratum in: Lancet Neurol. 2019 Aug;18(8):e7.

PMID:
31122491
14.

High multiplicity infection following transplantation of hepatitis C virus-positive organs.

Zahid MN, Wang S, Learn GH, Abt PL, Blumberg EA, Reese PP, Goldberg DS, Shaw GM, Bar KJ.

J Clin Invest. 2019 May 21;129(8):3134-3139. doi: 10.1172/JCI127203.

15.

Con: Use of Hepatitis C Virus-Positive Donors Should Be Restricted to Research Protocols.

Lee GS, Anesi JA, Besharatian BD, Bittermann T, Hamel S, Goldberg DS.

Clin Liver Dis (Hoboken). 2018 Nov 6;12(4):105-108. doi: 10.1002/cld.744. eCollection 2018 Oct. Review. No abstract available.

16.

Donation After Circulatory Death Liver Procurement: Time to Consider More Options?

Sonnenberg EM, Goldberg DS.

Liver Transpl. 2019 Apr;25(4):533-534. doi: 10.1002/lt.25436. No abstract available.

17.

Characterization of early hepatic injury in HCV-negative recipients of HCV-infected kidneys.

Mazur RD, Abt PL, Blumberg EA, Bloom RD, Reddy KR, Reese PP, Goldberg DS.

Clin Transplant. 2019 Apr;33(4):e13494. doi: 10.1111/ctr.13494. Epub 2019 Mar 6. No abstract available.

PMID:
30779252
18.

Transplanting hepatitis C virus-infected hearts into uninfected recipients: A single-arm trial.

McLean RC, Reese PP, Acker M, Atluri P, Bermudez C, Goldberg LR, Abt PL, Blumberg EA, Van Deerlin VM, Reddy KR, Bloom RD, Hasz R, Suplee L, Sicilia A, Woodards A, Zahid MN, Bar KJ, Porrett P, Levine MH, Hornsby N, Gentile C, Smith J, Goldberg DS.

Am J Transplant. 2019 Sep;19(9):2533-2542. doi: 10.1111/ajt.15311. Epub 2019 Mar 20.

PMID:
30768838
19.

Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.

Sawinski D, Forde KA, Lo Re V 3rd, Goldberg DS, Cohen JB, Locke JE, Bloom RD, Brensinger C, Weldon J, Shults J, Reese PP.

Am J Kidney Dis. 2019 Jun;73(6):815-826. doi: 10.1053/j.ajkd.2018.11.009. Epub 2019 Jan 29.

PMID:
30704882
20.

Incidence and Mortality of Acute-on-Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis.

Mahmud N, Kaplan DE, Taddei TH, Goldberg DS.

Hepatology. 2019 May;69(5):2150-2163. doi: 10.1002/hep.30494. Epub 2019 Mar 20.

PMID:
30615211
21.

Digitally enabled patient-reported outcome measures in cancer care - Authors' reply.

Heathcote LC, Goldberg DS, Eccleston C, Spunt SL, Simons LE, Sharpe L, Earp BD.

Lancet Oncol. 2019 Jan;20(1):e3. doi: 10.1016/S1470-2045(18)30910-0. No abstract available.

PMID:
30614475
22.

Introduction: Living with Pain in the Midst of the Opioid Crisis.

Dineen KK, Goldberg DS.

Narrat Inq Bioeth. 2018;8(3):189-193. doi: 10.1353/nib.2018.0058.

PMID:
30595575
23.

Transplanting livers from HCV-infected donors into HCV-negative recipients: Promise but mind the pitfalls.

Goldberg DS, Levitsky J.

Am J Transplant. 2019 May;19(5):1264-1265. doi: 10.1111/ajt.15193. Epub 2018 Dec 12. No abstract available.

PMID:
30480869
24.

Differences in Posttransplant Hepatocellular Carcinoma Recurrence by Etiology of Liver Disease.

Mahmud N, Shaked A, Olthoff KM, Goldberg DS.

Liver Transpl. 2019 Mar;25(3):388-398. doi: 10.1002/lt.25363.

PMID:
30362249
25.

Outcomes of Living-donor Liver Transplantation Using Grafts Heterozygous for α-1 Antitrypsin Gene Mutations.

Doshi SD, Wood L, Abt PL, Olthoff KM, Shaked A, Goldberg DS, Bittermann T.

Transplantation. 2019 Jun;103(6):1175-1180. doi: 10.1097/TP.0000000000002493.

PMID:
30335698
26.

Early Liver Transplantation for Alcoholic Hepatitis.

Solga SF, Goldberg DS, Spacek LA, Forde KA.

Gastroenterology. 2019 Jan;156(1):284-285. doi: 10.1053/j.gastro.2018.06.096. Epub 2018 Oct 10. No abstract available.

PMID:
30315772
27.

Advancing shared decision making for symptom monitoring in people living beyond cancer.

Heathcote LC, Goldberg DS, Eccleston C, Spunt SL, Simons LE, Sharpe L, Earp BD.

Lancet Oncol. 2018 Oct;19(10):e556-e563. doi: 10.1016/S1470-2045(18)30499-6. Epub 2018 Oct 1. Review.

PMID:
30303128
28.

Is the Pediatric End-stage Liver Disease Score Truly a Detriment to Pediatric Liver Allocation?

Mahmud N, Gadsden MM, Goldberg DS.

JAMA Pediatr. 2018 Nov 1;172(11):1013-1015. doi: 10.1001/jamapediatrics.2018.2886. No abstract available.

PMID:
30242354
29.

The Phillip Morris Foundation for a Smoke-Free World. A Cause for Concern.

Goldberg DS, Lederer DJ, MacKenzie EJ, Moss M, Samet JM, Schumacker PT, Wedzicha JA, Wynia MK.

Ann Am Thorac Soc. 2018 Nov;15(11):1269-1272. doi: 10.1513/AnnalsATS.201806-414GH. No abstract available.

30.

Maximizing utilization of the donor pool by appropriate classification of hepatitis C antibody-positive donors.

Goldberg DS, Wolfe CR.

Am J Transplant. 2018 Oct;18(10):2380-2381. doi: 10.1111/ajt.15077. Epub 2018 Sep 11. No abstract available.

31.

Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial.

Reese PP, Abt PL, Blumberg EA, Van Deerlin VM, Bloom RD, Potluri VS, Levine M, Porrett P, Sawinski D, Nazarian SM, Naji A, Hasz R, Suplee L, Trofe-Clark J, Sicilia A, McCauley M, Gentile C, Smith J, Niknam BA, Bleicher M, Reddy KR, Goldberg DS.

Ann Intern Med. 2018 Sep 4;169(5):273-281. doi: 10.7326/M18-0749. Epub 2018 Aug 7.

PMID:
30083748
32.

Pulse Oximetry Is Insensitive for Detection of Hepatopulmonary Syndrome in Patients Evaluated for Liver Transplantation.

Forde KA, Fallon MB, Krowka MJ, Sprys M, Goldberg DS, Krok KL, Patel M, Lin G, Oh JK, Mottram CD, Scanlon PD, Kawut SM; Pulmonary Vascular Complications of Liver Disease 2 Study Group.

Hepatology. 2019 Jan;69(1):270-281. doi: 10.1002/hep.30139. Epub 2018 Dec 18.

PMID:
30070715
33.

Hepatic Dysfunction in Deceased Donors in the Age of the Opioid Epidemic.

Gadsden MM, Goldberg DS.

Transplantation. 2018 Oct;102(10):e403. doi: 10.1097/TP.0000000000002368. No abstract available.

PMID:
30015704
34.

New Insights Into Optimal Timing of Hepatitis C Virus Treatment for Dialysis Patients Waitlisted for Kidney Transplant.

Goldberg DS, Reese PP.

Ann Intern Med. 2018 Aug 21;169(4):256-257. doi: 10.7326/M18-1718. Epub 2018 Jul 10. No abstract available.

PMID:
29987318
35.

Transplantation in foreign nationals: Lower rates of waitlist mortality and higher rates of lost to follow-up posttransplant.

Ferrante ND, Goldberg DS.

Am J Transplant. 2018 Nov;18(11):2663-2669. doi: 10.1111/ajt.15005. Epub 2018 Aug 13.

PMID:
29981179
36.

Quantifying the Effect of Transplanting Older Donor Livers Into Younger Recipients: The Need for Donor-recipient Age Matching.

Bittermann T, Goldberg DS.

Transplantation. 2018 Dec;102(12):2033-2037. doi: 10.1097/TP.0000000000002341.

PMID:
29965955
37.

Pain and the human condition.

Goldberg DS.

Med Humanit. 2018 Jun;44(2):72-73. doi: 10.1136/medhum-2018-011519. No abstract available.

PMID:
29903843
38.

Reply to: "Is obesity a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis?"

Sundaram V, Goldberg DS, Jalan R.

J Hepatol. 2018 Sep;69(3):758. doi: 10.1016/j.jhep.2018.05.022. Epub 2018 May 31. No abstract available.

PMID:
29859853
39.

Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.

Sundaram V, Jalan R, Ahn JC, Charlton MR, Goldberg DS, Karvellas CJ, Noureddin M, Wong RJ.

J Hepatol. 2018 Sep;69(3):617-625. doi: 10.1016/j.jhep.2018.04.016. Epub 2018 Apr 28.

PMID:
29709681
40.

Kidney transplant outcomes: Position in the match-run does not seem to matter beyond other donor risk factors.

Cohen JB, Shults J, Goldberg DS, Abt PL, Sawinski DL, Reese PP.

Am J Transplant. 2018 Jun;18(6):1577-1578. doi: 10.1111/ajt.14883. Epub 2018 May 11. No abstract available.

41.

Liver paired exchange: Can the liver emulate the kidney?

Mishra A, Lo A, Lee GS, Samstein B, Yoo PS, Levine MH, Goldberg DS, Shaked A, Olthoff KM, Abt PL.

Liver Transpl. 2018 May;24(5):677-686. doi: 10.1002/lt.25030.

42.

Important Facts About Organ Donation and OPO Performance.

Goldberg DS, Shafer T, Siminoff L.

Transplantation. 2018 May;102(5):e249-e250. doi: 10.1097/TP.0000000000002108. No abstract available.

43.

Indeterminate QuantiFERON-TB Gold Increases Likelihood of Inflammatory Bowel Disease Treatment Delay and Hospitalization.

Vajravelu RK, Osterman MT, Aberra FN, Roy JA, Lichtenstein GR, Mamtani R, Goldberg DS, Lewis JD, Scott FI.

Inflamm Bowel Dis. 2017 Dec 19;24(1):217-226. doi: 10.1093/ibd/izx019.

PMID:
29272482
44.

Hepatitis C virus genotyping of organ donor samples to aid in transplantation of HCV-positive organs.

Gentile C, Van Deerlin VM, Goldberg DS, Reese PP, Hasz RD, Abt P, Blumberg E, Farooqi MS.

Clin Transplant. 2018 Feb;32(2). doi: 10.1111/ctr.13172. Epub 2017 Dec 21.

PMID:
29220079
45.

Hepatitis C viremic donors for hepatitis C nonviremic liver transplant recipients: Ready for prime time?

Verna EC, Goldberg DS.

Liver Transpl. 2018 Jan;24(1):12-14. doi: 10.1002/lt.24985. No abstract available.

46.

Time out: NFL conflicts of interest with public health efforts to prevent TBI.

Bachynski KE, Goldberg DS.

Inj Prev. 2018 Jun;24(3):180-184. doi: 10.1136/injuryprev-2017-042404. Epub 2017 Nov 15. No abstract available.

PMID:
29142020
47.

Functional status, healthcare utilization, and the costs of liver transplantation.

Serper M, Bittermann T, Rossi M, Goldberg DS, Thomasson AM, Olthoff KM, Shaked A.

Am J Transplant. 2018 May;18(5):1187-1196. doi: 10.1111/ajt.14576. Epub 2017 Nov 26.

48.

Primary Sclerosing Cholangitis Is Not Rare Among Blacks in a Multicenter North American Consortium.

Goldberg DS, Levy C, Yimam K, Gordon SC, Forman L, Verna E, Yu L, Rahimi R, Schwarz K, Eksteen B, Pratt D, Boyer JL, Assis D, Bowlus C.

Clin Gastroenterol Hepatol. 2018 Apr;16(4):591-593. doi: 10.1016/j.cgh.2017.10.028. Epub 2017 Nov 2. No abstract available.

49.

Healthcare utilization after liver transplantation is highly variable among both centers and recipients.

Bittermann T, Hubbard RA, Serper M, Lewis JD, Hohmann SF, VanWagner LB, Goldberg DS.

Am J Transplant. 2018 May;18(5):1197-1205. doi: 10.1111/ajt.14539. Epub 2017 Nov 17.

50.

Outcomes of organ transplants when the donor is a prior recipient.

Lee GS, Goldberg DS, Levine MH, Abt PL.

Am J Transplant. 2018 Feb;18(2):492-503. doi: 10.1111/ajt.14536. Epub 2017 Nov 21.

Supplemental Content

Loading ...
Support Center